Zurueck zur Suche

Reporte zur Charge UT7731MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CT 3 MA 2 TX 1 NY 1 OH 1 CA 1 NH 1

VAERS 2596160

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

kritisch
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
14.03.2023
Impfdatum
11.03.2023
Beginn
11.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Coma scale Fall Muscle spasms Syncope

Symptomtext

PATIENT RECEIVED THE ABOVE FULL SET OF VACCINES. UPON COMPLETION OF VACCINE ADMINISTRATION, PATIENT WAS LEAVING VACCINE ROOM WHEN HE EXPERINCED SOME DEGREE OF BODY SPASMS AND SYNCOPE, HE FELL TO THE FLOOR. PATIENT WAS IMMEDIATELY ASSISTED BY MEDICAL STAFF AND TRANSFERRED TO EXAM ROOM. PATIENT WAS ASSESSED BY SITE AND FOUND TO BE VITALLY STABLE, AAOX4, GCS 15. PATIENT STATED HE FELT FINE AND SPENT THE REST OF THE NIGHT IN OBSERVATION. PATIENT HAD A STABLE NIGHT WITHOUT ANY FURTHER INCIDENTS NOR COMPLICATIONS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
FULL HEAD TO TOE ASSESSMENT BY MD ON SITE.
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2562987

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

schwer
Staat
NY
Alter
5,0
Geschlecht
F
Eingang
19.01.2023
Impfdatum
06.01.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye swelling Ocular hyperaemia Oculorespiratory syndrome Respiratory distress

Symptomtext

oculorespiratory syndrome; little respiratory distress; red swollen eyes; red swollen eyes; Initial information received on 13-Jan-2023 regarding an unsolicited valid serious case from other health professional. This case involves a 5-year-old female patient who experienced oculorespiratory syndrome after receiving vaccine influenza quadrival A-B vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 06-Jan-2023, the patient received suspect influenza quadrival A-B vaccine at a dose of 0.5 ml total (lot UT7731MA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for Immunization. On an unknown date the patient developed a serious oculorespiratory syndrome (oculorespiratory syndrome), little respiratory distress (respiratory distress), red swollen eyes (eye swelling, ocular hyperaemia) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Symptoms were resolving. Action taken: Not applicable. Corrective treatment: Not reported. Outcome: Unknown for the event oculorespiratory syndrome. Seriousness criteria: Medically significant; Sender's Comments: Sanofi company comment dated 17-Jan-2023: This case involves a 5-year-old female patient who experienced oculorespiratory syndrome after receiving vaccine influenza quadrival A-B vaccine [Fluzone QIV]. Additional information regarding condition at the time of vaccination, concomitant medication, medical history, lab tests would be needed for complete assessment of the case. Based upon the reported information, the role of vaccine cannot be assessed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2533333

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

mild
Staat
MA
Alter
4,0
Geschlecht
M
Eingang
15.12.2022
Impfdatum
12.12.2022
Beginn
13.12.2022
Tage bis Beginn
1,0
Dosis
5
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site macule Injection site rash Pruritus Rash

Symptomtext

Localized rash around influenza vaccine site, that subsequently generalized to total body rash supports vaccine reaction to influenza vaccine. Pt. otherwise appears well. Rash does not look like IgE mediated rash- ie skin lesions do not look like hives. Advised oral Benadryl q 4 to 6 hours prn itching. Discussed question of influenza vaccine allergy. Advised father I would list the vaccine as allergy, but cannot conclude 100% that rash is true allergy based on exam of rash. Father provided list of allergists- would consider allergy assessment next year before making decision about flu vaccine, consider vaccine under supervision of allergist. Pt. is here for evaluation of a rash in association with flu vaccine received two days ago. Mother forwarded picture day after vaccine showing what appears to be local swollen erythematous reaction, surrounded by smaller macular appearing lesions. Father notes rash progressed, total body yesterday, and has seemed a little itchy. No breathing difficulties reported, no vomiting or diarrhea, no fever.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2521729

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

mild
Staat
OH
Alter
0,2
Geschlecht
F
Eingang
30.11.2022
Impfdatum
29.11.2022
Beginn
29.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Decreased appetite Fatigue Poor feeding infant Vomiting

Symptomtext

Mom reports pt. had one episode of vomiting after the vaccines. Then pt. had low appetite, refusing to breast feed. Took 2 oz. formula only for 12 hours. Pt was more tired than usual. Mom took pt. to ED for evaluation. Tylenol given at hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Umbilical Granuloma
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2698872

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
19.10.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

2 of their staff members received expired FLUZONE QIV NP with no reported adverse event; Initial information received on 13-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient(s) who received expired Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml of suspect Influenza quadrival a-b vaccine Suspension for injection (lot number: UT7731MA, Expiry date: 30-Jun-2023) via unknown route in unknown administration site for immunization. On an unknown date, the patient(s) received expired Influenza Quadrival A-B Vaccine with no reported adverse event (expired product administered) (latency: same day). It was reported, Nurse explains that they share a building with another program; explains that the other program had been storing FLUZONE QIV NP that was past expiration date, and the other program had sent the expired product to them; states that 2 staff members were given expired FLUZONE QIV NP. He asks if there is any extension on the expiration date; asks if it is safe to use: No additional information available at time of call; caller declined to respond to questions and has accepted follow-up. This situation is reported as a medication error due to expired product was administered. Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2612244

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

gering
Staat
CT
Alter
0,3
Geschlecht
M
Eingang
10.04.2023
Impfdatum
06.12.2022
Beginn
06.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient given influenza vaccine at 4 months old, when the minimum age for first influenza vaccine is 6 months old. Patient came in for nurse visit with sibling for flu shots, and the age of the patient was overlooked. No side effects reported

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2559177

UNKNOWN MANUFACTURER · INFLUENZA (SEASONAL) (NO BRAND NAME) · Charge UT7731MA

gering
Staat
CT
Alter
16,0
Geschlecht
F
Eingang
13.01.2023
Impfdatum
09.01.2023
Beginn
09.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Medication error No adverse event

Symptomtext

mistakenly received second FLUZONE QIV NP injection of the season on 09JAN2023 one month after receiving their first FLUZONE QIV NP vaccination. (with no reported adverse event); Initial information received on 10-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 year old female patient who had mistakenly received second fluzone qiv np injection of the season on 09jan2023 one month after receiving their first fluzone qiv np vaccination. (with no reported adverse event) after receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 09-Jan-2023, the patient received a dose 2 of 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE for suspension for injection (lot: UT7731MA, expiry date: 30-Jun-2023, strength not reported) via intramuscular route in the left deltoid for Influenza immunization. On 09-JAN-2023, the patient developed a non-serious event mistakenly received second fluzone qiv np injection of the season on 09-jan-2023 one month after receiving their first fluzone qiv np vaccination. (with no reported adverse event) (inappropriate schedule of product administration) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. No lab data was available. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2555984

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

gering
Staat
CT
Alter
16,0
Geschlecht
F
Eingang
10.01.2023
Impfdatum
09.01.2023
Beginn
09.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Wrong product administered

Symptomtext

Vaccine administration error. Order Bexsero vaccine but influenza vaccine was given instead in error. Influenza vaccine had already been received this flu season.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
scoliosis
Andere Medikamente
Junel
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2544711

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

gering
Staat
MA
Alter
0,6
Geschlecht
M
Eingang
28.12.2022
Impfdatum
27.12.2022
Beginn
27.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered No adverse event

Symptomtext

COVID 19 bivalent booster given as a 2nd dose. no adverse event to report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
common cold on set 11/23
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2526630

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7731MA

gering
Staat
NH
Alter
14,0
Geschlecht
F
Eingang
08.12.2022
Impfdatum
08.12.2022
Beginn
08.12.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered

Symptomtext

Pfizer monovalent Covid 19 vaccine given inadvertantly as booster dose instead of Bivalent. Patient tolerated well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
anxiety disorder asthma atopic dermatitis ADHD Diplegic cerebral palsy Tic disorder menhorragia
Andere Medikamente
Guanfacine, albuterol
Allergien
Peanut
Vorherige Impfungen
-